Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Eli Lilly and Company    LLY

ELI LILLY AND COMPANY

(LLY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Eli Lilly and : , Incyte Say FDA Grants EUA for Baricitinib

11/19/2020 | 05:59pm EST

By Stephen Nakrosis

Eli Lilly and Co. and Incyte on Thursday said the U.S. Food and Drug Administration issued an emergency use authorization for Baricitinib to treat hospitalized patients with Covid-19.

The EUA "enables use of baricitinib in combination with remdesivir in hospitalized patients needing oxygen," the companies said.

The EUA is based on data from the Adaptive COVID-19 Treatment Trial conducted by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, the companies said. Among the findings, the companies said were that "patients treated with baricitinib in combination with remdesivir had a significant reduction in median time to recovery from 8 to 7 days compared to remdesivir," and "patients treated with baricitinib in combination with remdesivir were more likely to have a better clinical status at Day 15 compared to patients treated with remdesivir."

Baricitinib is an oral JAK inhibitor that was discovered by Incyte and licensed to Lilly, the companies said.

--Write to Stephen Nakrosis at stephen.nakrosis@wsj.com

(END) Dow Jones Newswires

11-19-20 1759ET

Stocks mentioned in the article
ChangeLast1st jan.
ELI LILLY AND COMPANY 2.19% 190.77 Delayed Quote.12.99%
INCYTE CORPORATION -1.61% 90.56 Delayed Quote.5.82%
All news about ELI LILLY AND COMPANY
01/16ELI LILLY AND : Insider at Eli Lilly (LLY) Makes Significant Sale of Stock
MT
01/15ELI LILLY AND : Lilly Confirms Date and Conference Call for Fourth-Quarter 2020 ..
PR
01/15ELI LILLY AND COMPANY : - Gabrielle Sulzberger Elected to Lilly Board of Directo..
AQ
01/15ELI LILLY AND : Lilly Invests $30 Million in Venture Fund for Underrepresented F..
DJ
01/15ELI LILLY AND : Invests $30 Million in Venture Capital Fund Targeting Early-Stag..
MT
01/14INSIDER TRENDS : Insider Prolongs 90-Day Selling Trend at Eli Lilly
MT
01/14ELI LILLY & CO : Change in Directors or Principal Officers, Financial Statements..
AQ
01/14ELI LILLY AND : Gabrielle Sulzberger Elected to Lilly Board of Directors
PR
01/14ELI LILLY AND : (LLY) sees Significant Insider Selling
MT
01/13Equities End Mixed as House Votes on Impeaching President Trump for Second Ti..
MT
More news
Financials (USD)
Sales 2020 24 408 M - -
Net income 2020 5 802 M - -
Net Debt 2020 11 301 M - -
P/E ratio 2020 30,0x
Yield 2020 1,56%
Capitalization 173 B 173 B -
EV / Sales 2020 7,55x
EV / Sales 2021 6,63x
Nbr of Employees 33 625
Free-Float 99,8%
Chart ELI LILLY AND COMPANY
Duration : Period :
Eli Lilly and Company Technical Analysis Chart | LLY | US5324571083 | MarketScreener
Technical analysis trends ELI LILLY AND COMPANY
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Average target price 181,58 $
Last Close Price 190,77 $
Spread / Highest target 19,0%
Spread / Average Target -4,82%
Spread / Lowest Target -37,1%
EPS Revisions
Managers and Directors
NameTitle
David A. Ricks Chairman, President & Chief Executive Officer
Joshua L. Smiley Chief Financial Officer & Senior Vice President
Timothy J. Garnett Chief Medical Officer & VP-Global Medical
Aarti S. Shah Chief Information & Digital Officer, Senior VP
Daniel M. Skovronsky Chief Scientific Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
ELI LILLY AND COMPANY12.99%172 949
JOHNSON & JOHNSON1.86%421 997
ROCHE HOLDING AG2.48%305 385
NOVARTIS AG1.97%218 041
MERCK & CO., INC.1.93%210 954
PFIZER INC.-0.30%203 993